Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187889 · ClinicalTrials.gov registry record · Phase 4
EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia
A Phase 4 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT00187889 is a Phase 4 study that has completed, run by University of Florida. The registered enrollment target is 70 participants.
The verdict
NCT00187889, a Phase 4 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
Some women have chest pain even without having a blockage in one of the major blood vessels that supplies blood to the heart. In many of these women the microscopic (small) blood vessels in the heart do not function normally. This study seeks to determine if treatment with eplerenone, a commercially available diuretic, can improve the function of these microscopic blood vessels and, possibly, improve the chest pain.
Interventions
- DRUG Eplerenone
- DRUG Placebo or sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2004-08 |
| Est. Completion | 2011-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187889
The ClinicalTrials.gov registry entry for NCT00187889 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Eplerenone is the first listed.
NCT00187889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187889 about?
NCT00187889 is a clinical study titled "EWISE: Study of Eplerenone in Women With Chest Pain, Coronary Vascular Dysfunction and Evidence of Myocardial Ischemia". Some women have chest pain even without having a blockage in one of the major blood vessels that supplies blood to the heart. In many of these women the microscopic (small) blood vessels in the heart do not function normally. This study seeks to determine if treatment with eplerenone, a commercially...
What is the current status of trial NCT00187889?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2004-08. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00187889?
The interventions under investigation include: Eplerenone (DRUG), Placebo or sugar pill (DRUG).
Who is sponsoring clinical trial NCT00187889?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.